A detailed history of Israel Englander (Millennium Management LLC) transactions in Replimune Group, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 3,118,035 shares of REPL stock, worth $38.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,118,035
Previous 461,862 575.1%
Holding current value
$38.3 Million
Previous $3.77 Million 643.76%
% of portfolio
0.01%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$5.01 - $9.46 $13.3 Million - $25.1 Million
2,656,173 Added 575.1%
3,118,035 $28.1 Million
Q1 2024

May 15, 2024

BUY
$6.87 - $9.31 $3.07 Million - $4.16 Million
446,836 Added 2973.75%
461,862 $3.77 Million
Q4 2023

Feb 14, 2024

SELL
$6.75 - $16.18 $2.62 Million - $6.29 Million
-388,847 Reduced 96.28%
15,026 $126,000
Q2 2023

Aug 14, 2023

SELL
$15.65 - $24.1 $2.88 Million - $4.44 Million
-184,088 Reduced 31.31%
403,873 $9.38 Million
Q1 2023

May 15, 2023

BUY
$17.48 - $29.09 $5.46 Million - $9.09 Million
312,465 Added 113.42%
587,961 $10.4 Million
Q4 2022

Feb 14, 2023

BUY
$17.09 - $27.91 $2.35 Million - $3.83 Million
137,383 Added 99.47%
275,496 $7.49 Million
Q3 2022

Nov 14, 2022

BUY
$15.6 - $21.15 $563,893 - $764,509
36,147 Added 35.45%
138,113 $2.39 Million
Q2 2022

Aug 15, 2022

BUY
$13.32 - $19.98 $1.18 Million - $1.77 Million
88,703 Added 668.8%
101,966 $1.78 Million
Q1 2022

May 16, 2022

SELL
$15.24 - $29.75 $1.38 Million - $2.69 Million
-90,563 Reduced 87.23%
13,263 $225,000
Q4 2021

Feb 14, 2022

BUY
$25.43 - $34.25 $391,469 - $527,244
15,394 Added 17.41%
103,826 $2.81 Million
Q3 2021

Nov 15, 2021

SELL
$28.98 - $39.54 $902,784 - $1.23 Million
-31,152 Reduced 26.05%
88,432 $2.62 Million
Q2 2021

Aug 16, 2021

BUY
$28.5 - $39.37 $677,217 - $935,509
23,762 Added 24.8%
119,584 $4.59 Million
Q1 2021

May 17, 2021

SELL
$30.22 - $45.57 $3.59 Million - $5.42 Million
-118,842 Reduced 55.36%
95,822 $2.92 Million
Q4 2020

Feb 16, 2021

BUY
$23.5 - $52.65 $4.79 Million - $10.7 Million
203,618 Added 1843.36%
214,664 $8.19 Million
Q3 2020

Nov 16, 2020

BUY
$18.85 - $27.0 $208,217 - $298,242
11,046 New
11,046 $254,000
Q2 2020

Aug 14, 2020

SELL
$9.76 - $25.95 $581,715 - $1.55 Million
-59,602 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$8.9 - $19.08 $309,648 - $663,831
-34,792 Reduced 36.86%
59,602 $594,000
Q4 2019

Feb 14, 2020

BUY
$11.61 - $17.21 $1.1 Million - $1.62 Million
94,394 New
94,394 $1.36 Million

Others Institutions Holding REPL

About Replimune Group, Inc.


  • Ticker REPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,306,700
  • Market Cap $605M
  • Description
  • Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...
More about REPL
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.